No Data
12 Health Care Stocks Moving In Monday's After-Market Session
Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026
12 Health Care Stocks Moving In Wednesday's After-Market Session
Express News | Ascendiant Capital Maintains Buy on Allarity Therapeutics, Raises Price Target to $10.25
Allarity Therapeutics Updates CEO Management and Compensation Agreement
Allarity Therapeutics GAAP EPS of -$0.17 Beats by $0.05
ProperMicheleV : I hope so.